Quick Answer
LB PHARMACEUTICALS INC reported R&D Expense of $16.74 million for fiscal year 2025.
LB PHARMACEUTICALS INC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $16.74M | -67.3% |
| 2024 | $51.17M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.42M | -77.3% | -77.3% |
| September 30, 2024 | $10.66M | — | — |
- LB PHARMACEUTICALS INC showed a decrease of -67.3% in R&D Expense compared to the prior fiscal year.
- Over the 2024–2025 period, LB PHARMACEUTICALS INC’s r&d expense has declined by 67.3% (from $51.17 million to $16.74 million).
- The most recent figure is from LB PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: